Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of ross river virus infection

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3719-3732

  Stoermer Burrack, Kristina A ^a   Hawman, David W ^a   Jupille, Henri J ^a   Oko, Lauren ^a   Minor, Marissa ^a,c   Shives, Katherine D ^a   Gunn, Bronwyn M ^b   Long, Kristin M ^b   Morrison, Thomas E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NONSTRUCTURAL PROTEIN 1;

ALPHAVIRUS INFECTION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MOUSE; NONHUMAN; NONSTRUCTURAL PROTEIN 1 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; ROSS RIVER ALPHA VIRUS INFECTION; TISSUE DISTRIBUTION; VIRUS LOAD; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ALPHAVIRUS INFECTIONS; ANIMAL STRUCTURES; ANIMALS; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; HOST-PATHOGEN INTERACTIONS; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTANT PROTEINS; MUTATION, MISSENSE; ROSS RIVER VIRUS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; VIRULENCE FACTORS;

EID: 84895447607     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02609-13     Document Type: Article

References (64)

1. Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC. 2001. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 75:10118-10131. http://dx.doi.org/10.1128/JVI.75.21 .10118-10131.2001.
2. Harley D, Sleigh A, Ritchie S. 2001. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 14:909-932. http://dx.doi.org/10.1128/CMR.14.4.909-932.2001.
3. Williams MC, Woodall JP, Gillett JD. 1965. O'nyong-nyong fever: an epidemic virus disease in East Africa. VII. Virus isolations from man and serological studies up to July 1961. Trans. R. Soc. Trop. Med. Hyg. 59: 186-197.
4. Weaver SC, Reisen WK. 2010. Present and future arboviral threats. Antiviral Res. 85:328-345. http://dx.doi.org/10.1016/j.antiviral.2009.10.008.
5. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 7:319-327. http://dx.doi .org/10.1016/S1473-3099(07)70107-X.
6. Pinheiro FP, Freitas RB, Travassos da Rosa JF, Gabbay YB, Mello WA, LeDuc JW. 1981. An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings. Am. J. Trop. Med. Hyg. 30:674-681.
7. Staples JE, Breiman RF, Powers AM. 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis. 49:942-948. http://dx.doi.org/10.1086/605496.
8. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. 2008. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island. Clin. Infect. Dis. 47:469-475. http://dx.doi.org/10.1086/590003.
9. Brighton SW, Prozesky OW, de la Harpe AL. 1983. Chikungunya virus infection. A retrospective study of 107 cases. S. Afr. Med. J. 63:313-315.
10. Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur MC, Sissoko D, Ezzedine K, Malvy D. 2010. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J. Clin. Virol. 47:85-88. http://dx.doi.org/10.1016/j.jcv.2009.11.014.
11. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, Charrel R, Tolou H. 2007. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86:123-137. http://dx.doi.org/10.1097/MD/0b013e3180 6010a5.
12. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V. 2009. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3:e389. http://dx.doi.org/10.1371 /journal.pntd.0000389.
13. Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT. 2007. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J. Virol. 81:5132-5143. http: //dx.doi.org/10.1128/JVI.02799-06.
14. Morrison TE, Simmons JD, Heise MT. 2008. Complement receptor 3 promotes severe Ross River virus-induced disease. J. Virol. 82:11263-11272. http://dx.doi.org/10.1128/JVI.01352-08.
15. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. 2006. Characterization of Ross River virus tropism and virusinduced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80:737-749. http://dx.doi.org/10.1128/JVI.80.2.737-749.2006.
16. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. 2011. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am. J. Pathol. 178:32-40. http://dx.doi.org/10.1016/j.ajpath.2010.11.018.
17. Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE. 2013. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J. Virol. 87:13878-13888. http://dx.doi.org/10.1128/JVI.02666-13.
18. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ, Mahalingam S. 2008. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J. Infect. Dis. 197:1585-1593. http://dx.doi.org/10.1086/587841.
19. Hoarau JJ, Jaffar Bandjee MC, Trotot PK, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P. 2010. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184:5914-5927. http://dx.doi.org/10.4049/jim munol.0900255.
20. Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, Brouqui P, Flahault A, Raoult D, Charrel RN. 2006. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg. Infect. Dis. 12:1493-1499. http://dx.doi.org/10.3201/eid1210 .060610.
21. Soden M, Vasudevan H, Roberts B, Coelen R, Hamlin G, Vasudevan S, La Brooy J. 2000. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 43:365-369. http://dx.doi.org/10.1002/1529-0131(200002)43:2365::AI D-ANR163.0.CO;2-E.
22. Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R. 1981. Cytology of synovial effusions in epidemic polyarthritis. Aust. N. Z. J. Med. 11:168-173. http://dx.doi.org/10.1111/j.1445-5994.1981.tb04226.x.
23. Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Despres P, Gessain A, Ceccaldi PE. 2007. Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One 2:e527. http://dx.doi.org/10.1371/journal.pone .0000527.
24. Hazelton RA, Hughes C, Aaskov JG. 1985. The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust. N. Z. J. Med. 15:336-339. http://dx.doi.org/10.1111/j.1445-5994.1985 .tb04048.x.
25. Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, Morrison TE. 2011. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology 410:216-227. http://dx.doi.org/10.1016/j.virol .2010.11.012.
26. Dalgarno L, Rice CM, Strauss JH. 1983. Ross River virus 26 S RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins. Virology 129:170-187. http://dx.doi.org/10.1016 /0042-6822(83)90404-X.
27. Kuhn RJ, Niesters HG, Hong Z, Strauss JH. 1991. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 182: 430-441. http://dx.doi.org/10.1016/0042-6822(91)90584-X.
28. Lindsay M, Oliveira N, Jasinska E, Johansen C, Harrington S, Wright AE, Smith D. 1996. An outbreak of Ross River virus disease in Southwestern Australia. Emerg. Infect. Dis. 2:117-120. http://dx.doi.org/10.3201 /eid0202.960206.
29. Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, Morrison TE. 2012. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J. Immunol. 189:4047-4059. http://dx.doi.org/10.4049/jimmunol.1201240.
30. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. 2005. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat. Med. 11: 1059-1065. http://dx.doi.org/10.1038/nm1296.
31. + T cell accrual. Immunity 33:955-966. http://dx.doi .org/10.1016/j.immuni.2010.11.020.
32. Shabman RS, Morrison TE, Moore C, White L, Suthar MS, Hueston L, Rulli N, Lidbury B, Ting JP, Mahalingam S, Heise MT. 2007. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J. Virol. 81:237-247. http://dx.doi.org/10.1128/JVI.01590-06.
33. Meager A. 2002. Biological assays for interferons. J. Immunol. Methods 261:21-36. http://dx.doi.org/10.1016/S0022-1759(01)00570-1.
34. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877. http://dx.doi.org/10.1016/0092-8674(92) 90030-G.
35. Biron CA, Brossay L. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458-464. http://dx.doi .org/10.1016/S0952-7915(00)00241-7.
36. Ryman KD, Klimstra WB. 2008. Host responses to alphavirus infection. Immunol. Rev. 225:27-45. http://dx.doi.org/10.1111/j.1600-065X.2008 .00670.x.
37. Emeny JM, Morgan MJ. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43:247-252. http://dx.doi.org/10.1099/0022-1317-43-1-247.
38. Mosca JD, Pitha PM. 1986. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell. Biol. 6:2279-2283.
39. Strauss JH, Strauss EG. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
40. Wang HL, O'Rear J, Stollar V. 1996. Mutagenesis of the Sindbis virus nsP1 protein: effects on methyltransferase activity and viral infectivity. Virology 217:527-531. http://dx.doi.org/10.1006/viro.1996.0147.
41. Tomar S, Narwal M, Harms E, Smith JL, Kuhn RJ. 2011. Heterologous production, purification and characterization of enzymatically active Sindbis virus nonstructural protein nsP1. Protein Expr. Purif. 79:277-284. http://dx.doi.org/10.1016/j.pep.2011.05.022.
42. Faragher SG, Meek AD, Rice CM, Dalgarno L. 1988. Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus. Virology 163:509-526. http://dx.doi.org/10.1016/0042-6822(88)90292-9.
43. Lulla V, Sawicki DL, Sawicki SG, Lulla A, Merits A, Ahola T. 2008. Molecular defects caused by temperature-sensitive mutations in Semliki Forest virus nsP1. J. Virol. 82:9236-9244. http://dx.doi.org/10.1128/JVI .00711-08.
44. Wang YF, Sawicki SG, Sawicki DL. 1991. Sindbis virus nsP1 functions in negative-strand RNA synthesis. J. Virol. 65:985-988.
45. Ahola T, Kaariainen L. 1995. Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc. Natl. Acad. Sci. U. S. A. 92:507-511. http://dx.doi .org/10.1073/pnas.92.2.507.
46. Ahola T, Laakkonen P, Vihinen H, Kaariainen L. 1997. Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities. J. Virol. 71:392-397.
47. Mi S, Durbin R, Huang HV, Rice CM, Stollar V. 1989. Association of the Sindbis virus RNA methyltransferase activity with the nonstructural protein nsP1. Virology 170:385-391. http://dx.doi.org/10.1016/0042-6822 (89)90429-7.
48. Scheidel LM, Durbin RK, Stollar V. 1989. SVLM21, a Sindbis virus mutant resistant to methionine deprivation, encodes an altered methyltransferase. Virology 173:408-414. http://dx.doi.org/10.1016/0042-6822 (89)90553-9.
49. Scheidel LM, Stollar V. 1991. Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. Virology 181:490-499. http://dx.doi.org/10.1016/0042-6822(91)90881-B.
50. Gorchakov R, Frolova E, Sawicki S, Atasheva S, Sawicki D, Frolov I. 2008. A new role for ns polyprotein cleavage in Sindbis virus replication. J. Virol. 82:6218-6231. http://dx.doi.org/10.1128/JVI.02624-07.
51. Frolova EI, Fayzulin RZ, Cook SH, Griffin DE, Rice CM, Frolov I. 2002. Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J. Virol. 76:11254-11264. http://dx.doi.org/10.1128/JVI.76.22.11254-11264.2002.
52. Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP. 2010. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J. Virol. 84:10877-10887. http://dx .doi.org/10.1128/JVI.00949-10.
53. Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD. 2012. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology 425: 103-112. http://dx.doi.org/10.1016/j.virol.2011.12.020.
54. Gardner CL, Yin J, Burke CW, Klimstra WB, Ryman KD. 2009. Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice. Virology 390:338-347. http://dx.doi.org/10.1016/j.virol.2009.05.030.
55. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74:3366-3378. http://dx.doi.org/10.1128/JVI.74.7.3366-3378.2000.
56. Ryman KD, Meier KC, Gardner CL, Adegboyega PA, Klimstra WB. 2007. Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons. Virology 368:273-285. http: //dx.doi.org/10.1016/j.virol.2007.06.039.
57. Wollish AC, Ferris MT, Blevins LK, Loo YM, Gale M, Jr, Heise MT. 2013. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology 435:269-280. http://dx.doi.org/10.1016/j.virol.2012.09.008.
58. White LJ, Wang JG, Davis NL, Johnston RE. 2001. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5= untranslated region. J. Virol. 75:3706-3718. http://dx.doi.org/10.1128/JVI.75.8.3706-3718.2001.
59. Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, Anraku I, Kumagai Y, Loo YM, Gale M, Jr, Akira S, Khromykh AA, Suhrbier A. 2012. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J. Virol. 86:9888-9898. http://dx.doi .org/10.1128/JVI.00956-12.
60. Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML. 2012. Independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J. Immunol. 188:2967-2971. http://dx.doi.org/10.4049/jimmunol.1103185.
61. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML. 2010. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J. Exp. Med. 207:429-442. http://dx.doi.org/10.1084/jem .20090851.
62. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. 2008. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 4:e29. http://dx.doi .org/10.1371/journal.ppat.0040029.
63. Lidbury BA, Rulli NE, Musso CM, Cossetto SB, Zaid A, Suhrbier A, Rothenfluh HS, Rolph MS, Mahalingam S. 2011. Identification and characterization of a Ross River virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon. J. Virol. 85:5651-5663. http://dx.doi.org /10.1128/JVI.01189-10.
64. Rosenblum CI, Stollar V. 1999. SVMPA, a mutant of Sindbis virus resistant to mycophenolic acid and ribavirin, shows an increased sensitivity to chick interferon. Virology 259:228-233. http://dx.doi.org/10.1006/viro .1999.9775.